Literature DB >> 11425699

Antacid increases survival of Vibrio vulnificus and Vibrio vulnificus phage in a gastrointestinal model.

J Koo1, D L Marshall, A DePaola.   

Abstract

Viable counts of three strains of Vibrio vulnificus and its phage were determined during exposure to a mechanical gastrointestinal model with or without antacid for 9 h at 37 degrees C. V. vulnificus was eliminated (>4-log reduction) within 30 min in the gastric compartment (pH decline from 5.0 to 3.5). Viable V. vulnificus cells delivered from the gastric compartment during the first 30 min of exposure reached 10(6) to 10(8) CFU/ml in the intestinal compartment after 9 h (pH 7.0). Phages were eliminated within 45 min in the gastric compartment (pH decline from 5.1 to 2.5). Less than a 2-log reduction of phage was observed in the intestinal compartment after 9 h (pH 7.0). When the gastric compartment contained antacid V. vulnificus counts decreased slightly (<2 log) during 2 h of exposure (pH decline from 7.7 to 6.0), while counts in the intestinal compartment (pH 7.5) reached 10(7) to 10(9) CFU/ml. Phage numbers decreased 1 log after 2 h in the gastric compartment (pH decline from 7.7 to 5.7) containing antacid and decreased 1 log in the intestinal compartment (pH 7.6) after 9 h. Presence of antacid in the gastric compartment of the model greatly increased the ability of both V. vulnificus and its phage to survive simulated gastrointestinal transit and may be a factor involved with oyster-associated illness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425699      PMCID: PMC92958          DOI: 10.1128/AEM.67.7.2895-2902.2001

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  36 in total

1.  Acid-sensitive enteric pathogens are protected from killing under extremely acidic conditions of pH 2.5 when they are inoculated onto certain solid food sources.

Authors:  S R Waterman; P L Small
Journal:  Appl Environ Microbiol       Date:  1998-10       Impact factor: 4.792

2.  Upper gastrointestinal (GI) pH in young, healthy men and women.

Authors:  J B Dressman; R R Berardi; L C Dermentzoglou; T L Russell; S P Schmaltz; J L Barnett; K M Jarvenpaa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

3.  Comparative efficacy of cimetidine, famotidine, ranitidine, and mylanta in postoperative stress ulcers. Gastric pH control and ulcer prevention in patients undergoing coronary artery bypass graft surgery.

Authors:  P H Lamothe; E Rao; A J Serra; J Castellano; C L Woronick; K W McNicholas; G M Lemole
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

4.  Self-Directed Treatment of Intermittent Heartburn: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Evaluation of Antacid and Low Doses of an H(2)-Receptor Antagonist (Famotidine).

Authors:  Thomas J. Simon; Roger G. Berlin; Andrea H. Gardner; Laura A. Stauffer; A. Lawrence Gould; Albert J. Getson
Journal:  Am J Ther       Date:  1995-05       Impact factor: 2.688

5.  Impact of acid on survival of Vibrio vulnificus and Vibrio vulnificus phage.

Authors:  J Koo; A DePaola; D L Marshall
Journal:  J Food Prot       Date:  2000-08       Impact factor: 2.077

6.  Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells.

Authors:  P L Conway; S L Gorbach; B R Goldin
Journal:  J Dairy Sci       Date:  1987-01       Impact factor: 4.034

7.  Clinical features and an epidemiological study of Vibrio vulnificus infections.

Authors:  C O Tacket; F Brenner; P A Blake
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

8.  The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium.

Authors:  A Berchieri; M A Lovell; P A Barrow
Journal:  Res Microbiol       Date:  1991-06       Impact factor: 3.992

9.  Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.

Authors:  M Feldman
Journal:  JAMA       Date:  1996-05-08       Impact factor: 56.272

10.  Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.

Authors:  Y F Ghoos; B D Maes; B J Geypens; G Mys; M I Hiele; P J Rutgeerts; G Vantrappen
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  8 in total

1.  Differences in survival among 13 Listeria monocytogenes strains in a dynamic model of the stomach and small intestine.

Authors:  Ioanna M Barmpalia-Davis; Ifigenia Geornaras; Patricia A Kendall; John N Sofos
Journal:  Appl Environ Microbiol       Date:  2008-06-27       Impact factor: 4.792

2.  Complete genome sequence of Vibrio vulnificus bacteriophage SSP002.

Authors:  Hyun Sung Lee; Slae Choi; Sang Ho Choi
Journal:  J Virol       Date:  2012-07       Impact factor: 5.103

3.  Cholera Outbreak due to Raw Seafood Consumption in South Korea, 2016.

Authors:  Jeong Hyun Kim; Jin Lee; Sahyun Hong; Sangwon Lee; Hae-Young Na; Young-Il Jeong; Eun Jin Choi; Junyoung Kim; Hyo Sun Kawk; Enhi Cho
Journal:  Am J Trop Med Hyg       Date:  2018-05-17       Impact factor: 2.345

4.  Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture.

Authors:  Katsunori Mizoguchi; Masatomo Morita; Curt R Fischer; Masatoshi Yoichi; Yasunori Tanji; Hajime Unno
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

5.  Adaptation of Escherichia coli O157:H7 to pH alters membrane lipid composition, verotoxin secretion, and resistance to simulated gastric fluid acid.

Authors:  Hyun-Gyun Yuk; Douglas L Marshall
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

6.  Genomic, proteomic and physiological characterization of a T5-like bacteriophage for control of Shiga toxin-producing Escherichia coli O157:H7.

Authors:  Yan D Niu; Kim Stanford; Andrew M Kropinski; Hans-Wolfgang Ackermann; Roger P Johnson; Yi-Min She; Rafiq Ahmed; Andre Villegas; Tim A McAllister
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

7.  In Vitro and In Vivo Gastrointestinal Survival of Non-Encapsulated and Microencapsulated Salmonella Bacteriophages: Implications for Bacteriophage Therapy in Poultry.

Authors:  Laura Lorenzo-Rebenaque; Danish J Malik; Pablo Catalá-Gregori; Clara Marin; Sandra Sevilla-Navarro
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06

8.  In Vivo Recovery of Bacteriophages and Their Effects on Clostridium perfringens-Infected Broiler Chickens.

Authors:  Hyun-Gwan Lee; Yoo-Bhin Kim; Sang-Hyeok Lee; Jun-Ok Moon; Jong-Pyo Chae; Yu-Jin Kim; Kyung-Woo Lee
Journal:  Vet Sci       Date:  2022-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.